1 Bridoux F,Delbes S,Sirac C,et al.Renal disorders associated with monoclonal gammopathies:diagnostic and therapeutic progress[J].Presse Med,2012,41(3 Pt 1):276-289. 2 Dispenzieri A,Kyle R,Merlini G,et al.International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders[J].Leukemia,2009,23(2):215-224. 3 Graziani MS,Merlini G.Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions[J].Expert Rev Mol Diagn,2014,14(1):55-66. 4 Song P,An ZM,Zhou XG,et al.Test of serum free light chain and its clinical significance in light chain multiple myeloma[J].Zhongguo Shi Yan Xue Ye Xue Za Zhi,2015,23(5):1357-1361. 5 张之南,沈悌.血液病诊断及疗效标准[M].第3版.北京:科学出版社,2008:232-235. 6 Bradwell AR,Carr-Smith HD,Graham PM,et al.Highly sensitive,automated immunoassay for immunoglobulin free light chains in serum and urine[J].Clin Chem,2001,47(4):673-680. 7 Campbell JP,Cobbold M,Wang Y,et al.Development of a highly-sensitive multiplex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine[J].J Immunol Methods,2013,391(1-2):1-13. 8 Hutchison CA,Cockwell P,Harding S,et al.Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes:an early marker of diabetic kidney disease[J].Expert Opin Ther Targets,2008,12(6):667-676. 9 Kaplan B,Golderman S,Aizenbud B,et al.Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies:a pilot study[J].Am J Hematol,2014,89(9):882-888. 10 Hanaoka M,Gono T,Kawaguchi Y,et al.Urinary free light chain is a potential biomarker for ISN/RPS class III/IV lupus nephritis[J].Rheumatology(Oxford),2013,52(12):2149-2157. 11 Cirit M,Uzüm A,Ozen P,et al.The value of serum immunoglobulin free light chain assessment in patients with monoclonal gammopathies and acute renal failure[J].Turk J Haematol,2012,29(4):385-391. 12 Dogaru M,Lazr V,Coriu D.Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation[J].Roum Arch Microbiol Immunol,2011,70(1):15-22. 13 Graziani MS,Merlini G.Measurement of free light chains in urine[J].Clin Chem,2001,47(11):2069-2070. 14 Fermand JP,Bridoux F,Kyle RA,et al.How I treat monoclonal gammopathy of renal significance(MGRS)[J].Blood,2013,122(22):3583-3590. 15 程艳杰,朱鸿,王旭,等.尿轻链检测在原发性高血压肾脏损伤中的诊断价值[J].中华检验医学杂志,2010,33(9):852-855. 16 Abraham RS,Katzmann JA,Clark RJ,et al.Quantitative analysis of serum free light chains.A new marker for the diagnostic evaluation of primary systemic amyloidosis[J].Am J Clin Pathol,2003,119(2):274-278. 17 Jenner E.Serum free light chains in clinical laboratory diagnostics[J].Clin Chim Acta,2014,427(6):15-20. 18 隋伟薇,姚宏静,王亚非,等.多发性骨髓瘤患者血清游离轻链检测及其临床意义[J].中华医学杂志,2007,87(44):3158-3160. 19 Le Bricon T,Bengoufa D,Benlakehal M,et al.Urinary free light chain analysis by the Freelite immunoassay:a preliminary study in multiple myeloma[J].Clin Biochem,2002,35(7):565-567. |